TCP
NITE

Tourbillon Capital Partners’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Tourbillon Capital Partners’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-170,952
Closed -$2.45M – 102
2018
Q1 		$2.45M Hold
170,952
– – 0.1% 55
2017
Q4 		$2.24M Buy
170,952
+19,952
+13% +$359K 0.08% 46
2017
Q3 		$2.9M Buy
+151,000
New +$3.26M 0.07% 52

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Tourbillon Capital Partners's NITE Position: Q2 2018 in Review

Tourbillon Capital Partners sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2018, closing a stake of 170,952 shares — an estimated $2.45M sold.

Tourbillon Capital Partners first reported a position in NITE in Q3 2017 and held it in 3 quarters. The position peaked at $2.9M in Q3 2017. 23 funds tracked by Wall St. Rank hold NITE as of Q2 2018.

  • Tourbillon Capital Partners reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 170,952 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2018, an estimated $2.45M.
  • Tourbillon Capital Partners first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 3 quarters.
  • Tourbillon Capital Partners's Nightstar Therapeutics plc American Depositary Shares position peaked at $2.9M in Q3 2017.
  • 23 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2018.

Based on Tourbillon Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.